Cannabis Stock Destroyed by 81% Decline on Clinical Trial Failure

2019-7-23 03:45

Intec Pharma Ltd. is a tiny company in the space of pot stocks, doing clinical research involving cannabis. But one of their drugs failed a Stage III clinical trial. Intec’s stock got crushed and lost 81 percent of its value.

Death of A Cannabis Stock Dream Intec has three drugs in its pipeline, including cannabis […]

The post Cannabis Stock Destroyed by 81% Decline on Clinical Trial Failure appeared first on CCN Markets

.

Similar to Notcoin - TapSwap on Solana Airdrops In 2024

origin »

Miner One token (MIO) на Currencies.ru

$ 0 (+0.00%)
Объем 24H $0
Изменеия 24h: 0.00 %, 7d: 0.00 %
Cегодня L: $0 - H: $0
Капитализация $0 Rank 99999
Доступно / Всего 0 MIO

clinical stock intec trial drugs failure decline